Cargando…

OTHR-07. A new framework for missing value tolerant data integration

Dataset integration is common practice to overcome limitations, e.g., in statistically underpowered omics datasets. This is of particular importance when analyzing rare tumor entities. However, combining datasets leads to the introduction of biases, so called 'batch effects', which are due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voß, Hannah, Schlumbohm, Simon, Wurlitzer, Marcus, Dottermusch, Matthias, Neumann, Philipp, Barwikowski, Philip, Schlüter, Hartmut, Krisp, Christoph, Neumann, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Others (Not Fitting Any Other Category)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164682/ http://dx.doi.org/10.1093/neuonc/noac079.546

Ejemplares similares

OTHR-42. Missing data tolerant integration of proteomic datasets enables the identification and characterization of brain cancer subtypes
por: Voss, Hannah, et al.
Publicado: (2022)

OTHR-07. CHRONIC ENCEPHALOPATHY DUE TO METHOTREXATE NEUROTOXICITY AS A RARE COMPLICATION IN A CHILD WITH LEUKEMIA: A CASE REPORT
por: Rafli, Achmad, et al.
Publicado: (2020)

OTHR-14. DIENCEPHALIC SYNDROME SECONDARY TO PITUITARY STALK THICKENING
por: Almeida, Carlos, et al.
Publicado: (2020)

OTHR-10. Pilocytic astrocytoma with respect to treatment
por: Hwee Tang, Phua, et al.
Publicado: (2022)

OTHR-17. Guidance for providing families with autopsy research results
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS
por: Winzent, Shelby, et al.
Publicado: (2020)

OTHR-38. The development of patient-derived models of pediatric brain tumors
por: Messiaen, Julie, et al.
Publicado: (2022)

OTHR-12. ANEURYSMAL BONE CYST RESEMBLING A POSTERIOR FOSSA TUMOR
por: Navarro, Luis Angel Arredondo, et al.
Publicado: (2020)

OTHR-15. Papillary tumor of the pineal region: case series of this rare pediatric entity
por: Shatara, Margaret, et al.
Publicado: (2022)

OTHR-16. Nutritional screening of U.S. pediatric central nervous system tumor survivors
por: Soja, Jacqueline, et al.
Publicado: (2022)

OTHR-46. Single institution experience using molecular analysis of pediatric CNS tumors
por: Bendel, Anne, et al.
Publicado: (2022)

OTHR-09. The prevalence and complex management of MEK inhibitor induced cutaneous side effects
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

OTHR-09. CENTRAL DIABETES INSIPIDUS: A RARE UNREPORTED SIDE EFFECT OF TEMOZOLOMIDE IN PEDIATRICS
por: Kuo, Christopher, et al.
Publicado: (2020)

OTHR-40. DICER 1- a rare , but important tumor driver in malignant progressive brain tumors
por: Fried, Iris, et al.
Publicado: (2022)

OTHR-12. Incidentalomas; should benign, indeterminate MRI findings be discussed at the paediatric neuro-oncology MDT
por: Large, Alexandra, et al.
Publicado: (2022)

OTHR-07. CIRCULATING MIRNAS AS A NON-INVASIVE MONITORING TOOL FOR PEDIATRIC BRAIN TUMORS
por: Coyle, Anne, et al.
Publicado: (2023)

OTHR-20. Precision neuro-oncology in the real world. Opportunity and challenges from a UK Oncology Centre
por: Apps, John, et al.
Publicado: (2022)

OTHR-11. The effects of the COVID-19 Pandemic on the time to diagnosis in pediatric patients with Primary central nervous system tumors
por: Canova, Tyler, et al.
Publicado: (2022)

OTHR-14. Responding to the COVID Challenge: evaluating a new method of adverse event recording in response to remote working.
por: Reiners, Stephanie, et al.
Publicado: (2022)

OTHR-45. Kids First Variant WorkBench: application to germline genomic discoveries in the Children's Brain Tumor Network
por: Guo, Yiran, et al.
Publicado: (2022)

OTHR-35. Health-Related Quality of Life and Social Determinants of Health within Children with Brain and Spinal Cord Tumors
por: Knight, Kelsey, et al.
Publicado: (2022)

OTHR-43. Composition of cell-free miRNA in cerebrospinal fluid and plasma as a monitoring tool for pediatric brain tumors
por: Anne, Coyle, et al.
Publicado: (2022)

OTHR-13. Effectivity and toxicity of off-label treatment with Trametinib monotherapy or in combination with Dabrafenib in children with relapsed or refractory brain tumor
por: Bregonje, S (Selena), et al.
Publicado: (2022)

HarmonizR enables data harmonization across independent proteomic datasets with appropriate handling of missing values
por: Voß, Hannah, et al.
Publicado: (2022)

OTHR-41. Amplification of the PLAG family genes – PLAGL1 and PLAGL2 – is a key feature of a novel embryonal CNS tumor type
por: Keck, Michaela-Kristina, et al.
Publicado: (2022)

OTHR-37. Pediatrics Cutaneous Reactions in Patient Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib
por: Gluck, Mirit, et al.
Publicado: (2022)

OTHR-06. Knowledge gap among health care providers in childhood central nervous system tumors: Result from an international multicenter survey
por: Rajagopal, Revathi, et al.
Publicado: (2022)

OTHR-39. Extraneural spreading of a diffuse leptomeningeal glioneuronal tumor in a child: patient-derived models show sensitivity to vinblastin and trametinib
por: Messiaen, Julie, et al.
Publicado: (2022)

OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)
por: Malbari, Fatema, et al.
Publicado: (2022)

OTHR-44. Building narrative competence on the neuro-oncology team: a narrative medicine approach to fostering unity and resilience for work with pediatric brain tumor families
por: Riley, Kathy
Publicado: (2022)

OTHR-36. Management of Central Diabetes Insipidus (CDI) with Low-Dose Vasopressin Infusion in Patients with Non-Germinomatous Germ Cell Tumors (NGGCT) Requiring Hyperhydration during Chemotherapy
por: Fitzgerald, Caroline, et al.
Publicado: (2022)

OTHR-18. A pilot study evaluating the access, utilization, and patient satisfaction of basic skin care products among pediatric patients prescribed medications that target the mitogen-activated protein kinase pathway
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-06. NARRATIVE MEDICINE AND THE PRACTICE OF PEDIATRIC NEURO-ONCOLOGY: GRAPPLING WITH THE UNTHINKABLE
por: Riley, Kathy, et al.
Publicado: (2023)

OTHR-11. THE IMPORTANCE AND INFLUENCE OF PATIENT FAMILY INVOLVEMENT IN PEDIATRIC NEURO-ONCOLOGY RESEARCH
por: Lyons, Nicole, et al.
Publicado: (2023)

OTHR-02. CHIMERIC AURORA A KINASE (AURKA) DEGRADERS EFFICIENTLY TARGET N-MYC
por: Valinciute, Gintvile, et al.
Publicado: (2023)

OTHR-03. CLASSIFICATION OF BRAIN TUMORS BY NANOPORE SEQUENCING OF CELL-FREE DNA FROM CEREBROSPINAL FLUID
por: Afflerbach, Ann-Kristin, et al.
Publicado: (2023)

OTHR-05. A LIVING EX VIVO PLATFORM FOR FUNCTIONAL, PERSONALIZED PEDIATRIC BRAIN CANCER DIAGNOSIS
por: Mann, Breanna, et al.
Publicado: (2023)

OTHR-01. SUCCESSFUL DEVELOPMENT OF A LOCAL-REGIONAL POST-MORTEM BRAIN TUMOR DONATION PROGRAM
por: Mark, Melissa, et al.
Publicado: (2023)

OTHR-10. COLLABORATIVE EFFORTS FOR HOSPITAL-BASED BIOBANK DEVELOPMENT AND OPTIMIZATION TO ENSURE QUALITY PEDIATRIC SPECIMENS FOR TRANSLATIONAL RESEARCH
por: Lebert, Brittany, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mcksamuhpuiis99u0kh98mkm13